We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

107 hedge funds and large institutions have $847M invested in Genomic Health, Inc. in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 43 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $793M → $847M (+$53.1M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less funds holding

Funds holding: 112 → 107 (-5)

28% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 43

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

37% less call options, than puts

Call options by funds: $1.79M | Put options by funds: $2.84M

Holders
107
Holders Change
-5
Holders Change %
-4.46%
% of All Funds
3.1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
31
Reduced
43
Closed
12
Calls
$1.79M
Puts
$2.84M
Net Calls
-$1.05M
Net Calls Change
+$240K

Top Buyers

Rank Fund Capital Flow
1
NTC
North Tide Capital
Massachusetts
+$33.5M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$13.1M
3
MRM
Michael R. Murphy
+$8.12M
4
CCM
Camber Capital Management
Massachusetts
+$7.67M
5
Millennium Management
Millennium Management
New York
+$2.81M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$14.9M
2
VAM
Visium Asset Management
New York
-$8.75M
3
Norges Bank
Norges Bank
Norway
-$5.62M
4
Citadel Advisors
Citadel Advisors
Florida
-$4.26M
5
CS
Credit Suisse
Switzerland
-$1.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMU
26
Pictet Asset Management (UK)
United Kingdom
$2.34M -$1.32M -47,400 -36%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$2.19M -$39K -1,400 -2%
SI
28
Scout Investments
Missouri
$2.09M – – –
PP
29
PDT Partners
New York
$2.06M – – –
OC
30
Oppenheimer & Co
New York
$1.81M -$223K -8,000 -11%
TCIM
31
TIAA CREF Investment Management
New York
$1.76M -$127K -4,563 -7%
BIM
32
BlackRock Investment Management
Delaware
$1.67M +$335 +12 +0%
Charles Schwab
33
Charles Schwab
California
$1.56M +$30.8K +1,106 +2%
CCM
34
Catapult Capital Management
New York
$1.46M +$1.44M +51,627 New
Wells Fargo
35
Wells Fargo
California
$1.46M +$2.26K +81 +0.2%
Jacobs Levy Equity Management
36
Jacobs Levy Equity Management
New Jersey
$1.24M +$1.22M +43,803 New
GCP
37
GSA Capital Partners
United Kingdom
$1.21M +$376K +13,500 +46%
MFAM
38
Motley Fool Asset Management
Virginia
$1.14M +$1.01M +36,179 New
Citadel Advisors
39
Citadel Advisors
Florida
$1.07M -$4.26M -152,802 -80%
KB
40
Kimelman & Baird
New York
$1.01M -$69.7K -2,500 -7%
AllianceBernstein
41
AllianceBernstein
Tennessee
$1M -$83.6K -3,000 -8%
RA
42
Royce & Associates
New York
$934K – – –
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$871K +$7.67K +275 +0.9%
William Blair & Company
44
William Blair & Company
Illinois
$790K -$19.5K -700 -2%
SCM
45
Stonebridge Capital Management
California
$769K -$72.3K -2,595 -9%
State Board of Administration of Florida Retirement System
46
State Board of Administration of Florida Retirement System
Florida
$751K -$20.9K -750 -3%
SO
47
STRS Ohio
Ohio
$711K -$69.7K -2,500 -9%
SIM
48
Spark Investment Management
New York
$693K +$471K +16,900 +222%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$659K -$416K -14,910 -39%
ProShare Advisors
50
ProShare Advisors
Maryland
$648K -$118K -4,221 -16%
1
2
3 4 5

GHDX Hedge Fund Activity: Q3 2014 in Review

107 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q3 2014, worth a combined $847M — up 6.7% from $793M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of GHDX and 8 opened new positions — a net loss of 4 holders — while 43 trimmed existing stakes and 31 added.

The largest buyer was North Tide Capital, adding an estimated $33.5M. The largest seller was Fidelity Investments, cutting an estimated $14.9M.

  • 107 institutional investors held Genomic Health, Inc. (GHDX) as of Q3 2014, down from 112 in Q2 2014.
  • Funds reported $847M of Genomic Health, Inc. stock for Q3 2014, up 6.7% quarter-over-quarter.
  • 8 funds opened new Genomic Health, Inc. positions in Q3 2014 and 12 closed out, a net change of -4 holders.
  • The largest Genomic Health, Inc. buyer in Q3 2014 was North Tide Capital, an estimated $33.5M added.
  • The largest Genomic Health, Inc. seller in Q3 2014 was Fidelity Investments, an estimated $14.9M sold.

Based on aggregated 13F filings for Q3 2014.